Abstract:The NLRP3 inflammasome is a multiprotein complex that plays a vital role in the innate immune system in response to microbial infections and endogenous danger signals. Aberrant activation of the NLRP3 inflammasome is implicated in a spectrum of inflammatory and autoimmune diseases, emphasizing the necessity for precise regulation of the NLRP3 inflammasome to maintain immune homeostasis. The protein level of NLRP3 is a limiting step for inflammasome activation, which must be tightly controlled to avoid detrimental consequences. Here, we demonstrate that ABHD8, a member of the α/β-hydrolase domain-containing (ABHD) family, interacts with NLRP3 and promotes its degradation through the chaperone-mediated autophagy (CMA) pathway. ABHD8 acts as a scaffold to recruit palmitoyltransferase ZDHHC12 to NLRP3 for its palmitoylation as well as subsequent CMA-mediated degradation. Notably, ABHD8 deficiency results in the stabilization of NLRP3 protein and promotes NLRP3 inflammasome activation. We further confirm that ABHD8 overexpression ameliorates LPS- or alum-triggered NLRP3 inflammasome activation in vivo. Interestingly, the nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impairs the ABHD8-NLRP3 association, resulting in an elevation in NLRP3 protein level and excessive inflammasome activation. These findings demonstrate that ABHD8 May represent a potential therapeutic target in conditions associated with NLRP3 inflammasome dysregulation.Abbreviations: 3-MA: 3-methyladenine; ABHD: α/β-hydrolase domain-containing; BMDMs: Bone marrow-derived macrophages; CFZ: carfilzomib; CHX: cycloheximide; CMA: chaperone-mediated autophagy; CQ: chloroquine; DAMPs: danger/damage-associated molecular patterns; HSPA8/HSC70: heat shock protein family A (Hsp70) member 8; LAMP2A: lysosomal associated membrane protein 2A; NH4Cl: ammonium chloride; NLRP3: NLR family pyrin domain containing 3; PAMPs: pathogen-associated molecular patterns; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.

ZAP facilitates NLRP3 inflammasome activation via promoting the oligomerization of NLRP3

YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3

ZDHHC5-mediated NLRP3 Palmitoylation Promotes NLRP3-NEK7 Interaction and Inflammasome Activation.

Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors

The human disease-associated gene ZNFX1 controls inflammation through inhibition of the NLRP3 inflammasome

NLRP3 Cys126 palmitoylation by ZDHHC7 promotes inflammasome activation

ABHD8 antagonizes inflammation by facilitating chaperone-mediated autophagy-mediated degradation of NLRP3

Zinc Finger Protein 91 Positively Regulates The Production Of Il-1 Beta In Macrophages By Activation Of Mapks And Non-Canonical Caspase-8 Inflammasome

Negative Regulatory Mechanisms of NLRP3 Inflammasome

NLRP3 Inflammasome—A Key Player in Antiviral Responses

C1q/tumour necrosis factor-related protein-9 aggravates lipopolysaccharide-induced inflammation via promoting NLRP3 inflammasome activation

Consecutive palmitoylation and phosphorylation orchestrates NLRP3 membrane trafficking and inflammasome activation

Negative Regulation Of Nod-Like Receptor Protein 3 Inflammasome Activation By T Cell Ig Mucin-3 Protects Against Peritonitis

NLRP3 Inflammasome and Inflammatory Bowel Disease

The Zebrafish NLRP3 Inflammasome Has Functional Roles in ASC-dependent Interleukin-1Β Maturation and Gasdermin E–mediated Pyroptosis

Recent Insights into the Regulatory Networks of NLRP3 Inflammasome Activation

Modulatory mechanisms of NLRP3: Potential roles in inflammasome activation

Role of NLRP3 Inflammasome in Digestive System Diseases

Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination.

The NLRP3 inflammasome: contributions to inflammation-related diseases